Results 111 to 120 of about 2,272 (175)

Multidrug-resistant Acinetobacter spp. bloodstream infections in hematologic patients: clinical characteristics, genomic features, and eravacycline-based combination therapy. [PDF]

BMC Infect Dis
Guo W, Li J, Yang N, Zhen S, Zhang T, Lin Q, Cao Y, Cao W, Pang A, Yang D, Chen X, Zhang R, Wei J, Ma Q, Zhai W, He Y, Zheng Y, Jiang E, Han M, Feng S.   +19 more
europepmc   +1 more source

Eravacycline as a Novel Option for Treating Multidrug-Resistant Gram-Negative and Gram-Positive Bacterial Infections: A Narrative Review. [PDF]

J Clin Med
Złotowska A, Kacer J, Dybko Z, Dudek M, Duszyńska W.   +4 more
europepmc   +1 more source

Stenotrophomonas maltophilia infections: Could eravacycline be a new weapon for clinicians?

: Stenotrophomonas maltophilia is an emerging, multidrug-resistant pathogen increasingly associated with nosocomial infections, particularly in immunocompromised patients such as those undergoing allogeneic hematopoietic stem cell transplantation or ...
De Cecchis, Lucio, Flammini, Sarah, Fanin, Renato, Moreal, Chiara, Giuliano, Simone, Prataviera, Francesca, Lazzarotto, Davide, Tascini, Carlo, Martini, Luca, Terrosu, Giovanni   +9 more
core  

Eravacycline-Cefiderocol Combination Therapy for Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infective Endocarditis: A Case Report and Brief Review of the Literature. [PDF]

Infect Drug Resist
Lou L, Li X, Zhang P, Wu H, Chen H, Ma J, Zhang K.   +6 more
europepmc   +1 more source

Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent. [PDF]

Cureus
Khanal P, Sapkota S, Karageorgiou I, Al Baghdadi T.   +3 more
europepmc   +1 more source

Case Report: Diagnosis and management of severe pneumonia caused by complex mixed infection with multidrug-resistant bacteria and fungi after liver retransplantation. [PDF]

Front Surg
Lu J, Xia Y, Wang H, Gao C, Niu X, Zhang Y, Zhang D.   +6 more
europepmc   +1 more source

Some Newer Antibiotics Active Against <i>Helicobacter pylori</i> and Anaerobic Bacteria and the Potential Benefits of Their Wider Availability in More Countries: A Narrative Review. [PDF]

Antibiotics (Basel)
Boyanova L, Boyanova LY, Medeiros J, Dimitrov G, Hadzhiyski P, Gergova R, Markovska R.   +6 more
europepmc   +1 more source

<i>In Vitro</i> Antibacterial Activity of Sulbactam-Durlobactam and Eravacycline Against Carbapenem-Resistant <i>Acinetobacter baumannii</i> in China and Analysis of Sulbactam-Durlobactam Resistance Mechanisms. [PDF]

Pol J Microbiol
He X, Ma S, Zhou Y, Wei J, Zhuo Z, Ma L.
europepmc   +1 more source

Recurrent Campylobacter jejuni bacteraemia with independent acquisition of carbapenem resistance in three ST9611 isolates: a case series in immunocompromised hosts. [PDF]

Gut Pathog
Ngiam JN, Koh MCY, Tung G, Tang F, Teo J, Chew KL.   +5 more
europepmc   +1 more source

The Safety of Eravacycline in the Treatment of Acute Bacterial Infection

Clinical Infectious Diseases, 2019
Hung-Jen, Tang, Chih-Cheng, Lai
openaire   +2 more sources